Mustang Bio Inc.

NASDAQ: MBIO · Real-Time Price · USD
1.74
-0.04 (-2.25%)
At close: Aug 15, 2025, 3:59 PM
1.69
-2.88%
After-hours: Aug 15, 2025, 07:52 PM EDT

Mustang Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 1.99M n/a n/a n/a 2.88M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 41K 996K 100K 300K 696K 363K 1.35M 698K 858K 834K n/a 699K 679K 692K 634K 540K 490K
Gross Profit
n/a -41K 996K -100K -300K -696K 2.52M -1.35M -698K -858K -834K n/a -699K -679K -692K -634K -540K -490K
Operating Income
-885K -253K -1.02M -1.46M -8.54M -5.23M -10.21M -11.66M -13.89M -16.32M -19.43M -18.85M -18.24M -19.64M -20.12M -17.08M -14.44M -15.09M
Interest Income
123K 100K 66K 48K 29K 41K 123K 115K 159K 453K 323K 216K 77K 73K 74K 75K 85K 134K
Pretax Income
-762K -153K -952K -1.41M -8.2M -5.19M -8.62M -10.06M -16.23M -16.69M -19.63M -19M -19.1M -19.8M -20.05M -17M -14.36M -14.96M
Net Income
-762K -153K -952K -1.41M -8.2M -5.19M -8.62M -10.06M -16.23M -18.24M -20.85M -19M -19.1M -19.95M -20.05M -17M -14.36M -14.96M
Selling & General & Admin
787K 1.22M -223K 1.4M 1.53M 1.43M 2.1M 2.13M 3.06M 2.32M 2.4M 3.39M 3.08M 3.35M 2.65M 2.36M 2.54M 3.47M
Research & Development
98K 964K 664K 57K 4.36M 3.52M 6.39M 9.48M 10.84M 14M 17.04M 15.46M 15.16M 16.29M 17.47M 14.71M 11.9M 11.62M
Other Expenses
n/a -1.97M 446K n/a -300K -411K n/a -332K 429K -351K -635K 669K n/a n/a 5.84M 630K 1M n/a
Operating Expenses
885K 212K 887K 1.46M 5.59M 4.54M 8.49M 11.28M 13.89M 15.97M 18.8M 18.18M 18.24M 19.64M 20.12M 17.08M 14.44M 15.09M
Interest Expense
n/a n/a 1K 1K 2K 1K n/a 4K 2.93M 1.18M 1.16M 1.03M 935K 230K 4K 3K 4K 4K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
885K 253K 1.88M 1.46M 5.89M 5.23M 8.86M 11.66M 13.89M 15.97M 18.8M 18.18M 18.24M 19.64M 20.12M 17.08M 14.44M 15.09M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.55M 1.22M n/a 77K 157K 4K 75K 85K n/a
Shares Outstanding (Basic)
40.21M 5.72M 8.69M 8.69M 8.69M 11.25M 9.22M 8.17M 8.13M 8.09M 7.16M 7.85M 7.65M 6.53M 5.86M 6.08M 5.84M 5.36M
Shares Outstanding (Diluted)
40.21M 5.72M 8.69M 8.69M 8.69M 11.25M 9.22M 8.17M 8.13M 8.09M 7.16M 7.85M 7.65M 6.53M 5.86M 6.08M 5.84M 5.36M
EPS (Basic)
-0.19 -0.05 -0.95 -0.16 -0.94 -0.46 -0.93 -1.23 -2 -2.25 -2.91 -2.42 -2.5 -3.06 -3.42 -2.8 -2.46 -2.79
EPS (Diluted)
-0.19 -0.05 -0.95 -0.16 -0.94 -0.46 -0.93 -1.23 -2 -2.25 -2.91 -2.42 -2.5 -3.06 -3.42 -2.8 -2.46 -2.79
EBITDA
-885K -253K -1.1M -1.36M -7.9M -4.49M -8.25M -9.67M -15.4M -14.66M -17.64M -17.14M -17.46M -18.89M -19.35M -16.37M -13.82M -14.46M
EBIT
-762K -153K -961K -1.41M -8.2M -5.19M -8.62M -10.05M -16.1M -15.52M -18.47M -17.96M -18.16M -19.57M -20.05M -17M -14.36M -14.95M
Depreciation & Amortization
n/a 41K 75K 51K 300K 696K 363K 382K 698K 858K 834K 819K 699K 679K 692K 634K 540K 490K